Table 2: Prognostic factors in cytoreductive surgery for isolated lymph node relapsing.

Authors Ferrero, et al. [31] Fotiu, et al. [29] Santillan, et al. [33] Uzan, et al. [32]
Patients 73 21 25 12
Mean age: Years 54 52 55 51
DFI: Months 18 21 16 21
Pre/post-SCS treatment
Chemotherapy 70 1 1 9
Radiotherapy 0 4 4 15
Chemotherapy + radiotherapy 0 3 1 17
None 3 0 2 1
PFS after relapsing: Months 46 21 10 44
OS after relapsing: Months 60 (64%) 60 (68%) 37 60 (71%)

DFI: Disease free interval; PFS: Progression free survival; OS: Overall survival; SCS: Secondary cytoreductive surgery.